Page 3 - Dakpha

3 Danesh Kimia Pharmed

Danesh Kimia Pharmed Co. (DAKPHA), was established in 2011 by a team of
highly skilled experts in order to invest on the production of generic pharmaceuti-
cal active ingredients and ready to use dosage forms.
Most of the produced molecules are among valuable and new pharmaceutical
molecules.
In addition, Dakpha group provides expert advice and consulting by excellent
professionals and experienced advisors.
DAKPHA has created a production line for anticancer active ingredients in Baran
Chemical and Pharmaceutical Co., molecules in low quantity with high value
such as Fingolimod, Nitisinone, Bosentan, etc. in Danesh Pharmaceutical
Development Co. and producing Opioid derivatives and other active pharmaceu-
tical ingredients in Alborz Pharmed Co.

Producer of Low-Volume High-Value (LVHV) Active Pharma-
ceuticals Ingredients
Producer of Hazardous and Anticancer Active Pharmaceutical
Ingredients and solid Dosage Forms
Producer of Opioid derivative and general Active Pharmaceutical
Ingredients